加拿大投资银行集团:维持Biodesix评级

证券之星
Apr 29, 2025

加拿大投资银行集团:维持Biodesix(BDSX.US)评级,由买入调整至买入评级,目标价由3.50美元调整至2.50美元。Biodesix(BDSX.US)公司简介:Biodesix Inc是一家专注于肺部疾病诊断解决方案的公司。该公司有一个单一的运营部门,专注于为客户提供诊断测试服务。公司为生物制药公司提供服务,包括诊断研究、临床试验测试以及伴随诊断的发现、开发和商业化。公司的收入来自两个...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10